IsoPlexis expands sales of its single-cell proteomic analysis platform, IsoLight and IsoCode Chip, to the pharmaceutical and life sciences markets in China BRANFORD, Conn. -- IsoPlexis Corporation (IsoPlexis), a privately held life sciences company at the forefront of single-cell analytics technology, announced today an exclusive agreement with Tekon Biotech, a leading instrumentation distributor, to distribute IsoPlexis' products [...]

NanoScreen is pleased to announce a strategic partnership with SCBIO, the official state affiliate of BIO, the US Biotechnology Innovation Organization. SCBIO is a nonprofit life sciences industry association and economic development organization. Learn more about SCBIO by visiting the SCBIO website:   https://www.scbio.org/cpages/home

Product Launch during 2018 BioProcess International in Boston. CITSens MeMo is a new, innovative, affordable, and easy to handle single-use wireless bi-parametric metabolic monitoring system that allows the continuous online / real-time measurement of glucose and lactate in cell cultures. Waedenswil (Zurich), Switzerland -- C-CIT Sensors AG, today announced the release of its new sensor product allowing to [...]

SANTA CLARA, Calif.--Agilent Technologies Inc. (NYSE: A) today announced that it has completed its acquisition of the Agilent-related business from Young In Scientific Co. Ltd. and its affiliates (“YI Scientific”). YI Scientific is a leading distributor of analytical and scientific instruments in South Korea and a long-time distributor of Agilent instruments and services. Agilent and YI [...]

New acquisition rounds out Diagenode’s epigenomics profiling services platform DENVILLE, N.J. AND LIEGE, BELGIUM Diagenode today announced the acquisition of NXT-Dx, an established epigenetics service provider based in Gent, Belgium. NXT-Dx provides a broad variety of start-to-finish epigenetics services including a number of targeted DNA methylation assays using pyrosequencing or Next-Generation Sequencing and Illumina’s Infinium [...]

FRANKLIN LAKES, N.J. -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Jeffrey W. Henderson has been elected to the company's board of directors. Henderson, 53, is the non-executive chairman of the board of Qualcomm, Inc. and serves on the board of directors at FibroGen, Inc. and Halozyme Therapeutics, Inc. as well as serving as an advisory [...]

Acquisition of US-based NuGEN expands Tecan's dedicated solutions offering into new market segment of next-generation sequencing (NGS) reagents and increases overall recurring revenues NuGEN provides innovative NGS kits and genomic sample prep reagents for the fastest growing field within the genomics area NuGEN to become part of Tecan's Life Sciences Business, leveraging Tecan's global presence and [...]

Dundee, UK: Ubiquigent Limited, a company focused on enabling and supporting ubiquitin system targeted drug discovery, announced today that it was awarded a new grant from Innovate UK as part of its Investor Accelerator Pilot to support a project entitled; ‘The development of novel compounds to seed a neurodegeneration drug discovery programme’.  The programme provides simultaneous [...]

Merck today announced that the Australian Patent Office has allowed the company’s patent application for the use of paired CRISPR nickases. DARMSTADT, GERMANY Patent covers paired Cas9 nickase technology to reduce off-target effects, advance gene therapy and research Expands company’s foundational CRISPR cutting and integration IP necessary to correct genetic defects in gene therapy patients [...]

Testa Analytical Solutions e.K has introduced a highly sensitive, online differential viscometer which can be used as part of a triple detector GPC/SEC system to determine the size and conformation of all types of synthetic polymers, biopolymers, proteins and peptides. Drawing upon over 30 years expertise, the new Testa Analytical detector incorporates technological innovations that dramatically reduce the [...]